在刑事司法环境中强制脱毒美沙酮维持治疗：美国的一个关键治疗障碍。
Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.
机构信息
Yale University School of Medicine, Section of Infectious Diseases, New Haven, CT 06510, USA.
出版信息
J Subst Abuse Treat. 2013 May-Jun;44(5):502-5. doi: 10.1016/j.jsat.2012.10.005. Epub 2013 Feb 22.
Abstract
The World Health Organization classifies methadone as an essential medicine, yet methadone maintenance therapy remains widely unavailable in criminal justice settings throughout the United States. Methadone maintenance therapy is often terminated at the time of incarceration, with inmates forced to withdraw from this evidence-based therapy. We assessed whether these forced withdrawal policies deter opioid-dependent individuals in the community from engaging methadone maintenance therapy in two states that routinely force inmates to withdraw from methadone (N = 205). Nearly half of all participants reported that concern regarding forced methadone withdrawal during incarceration deterred them engaging methadone maintenance therapy in the community. Participants in the state where more severe methadone withdrawal procedures are used during incarceration were more likely to report concern regarding forced withdrawal as a treatment deterrent. Methadone withdrawal policies in the criminal justice system may be a broader treatment deterrent for opioid-dependent individuals than previously realized. Redressing this treatment barrier is both a health and human rights imperative.
摘要
世界卫生组织将美沙酮列为基本药物，但美沙酮维持疗法在美国刑事司法系统中仍广泛无法获得。美沙酮维持疗法通常在监禁时终止，囚犯被迫停止这种基于证据的治疗。我们评估了这些强制戒毒政策是否会阻止社区中依赖阿片类药物的个体在两个经常强制囚犯停止美沙酮治疗的州接受美沙酮维持治疗（N=205）。几乎一半的参与者报告说，担心在监禁期间被迫美沙酮戒断会阻止他们在社区接受美沙酮维持治疗。在监禁期间使用更严重的美沙酮戒断程序的州的参与者更有可能报告担心强制戒断作为治疗障碍。刑事司法系统中的美沙酮戒断政策可能对依赖阿片类药物的个体构成比以前认识到的更广泛的治疗障碍。纠正这种治疗障碍既是健康和人权的当务之急。
相似文献
1
Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.在刑事司法环境中强制脱毒美沙酮维持治疗：美国的一个关键治疗障碍。
J Subst Abuse Treat. 2013 May-Jun;44(5):502-5. doi: 10.1016/j.jsat.2012.10.005. Epub 2013 Feb 22.
2
Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.美国监狱联合监禁中，美沙酮维持治疗与强制戒毒的对比：一项随机、开放标签试验。
Lancet. 2015 Jul 25;386(9991):350-9. doi: 10.1016/S0140-6736(14)62338-2. Epub 2015 May 28.
3
Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.在监禁期间继续美沙酮维持治疗与强制脱毒相比的可行性和效果。
J Addict Med. 2018 Mar/Apr;12(2):156-162. doi: 10.1097/ADM.0000000000000381.
4
"I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.“我以艰难的方式戒掉了。我被监禁了。”监禁期间美沙酮戒断及随后对药物辅助治疗的反感
J Subst Abuse Treat. 2016 Mar;62:49-54. doi: 10.1016/j.jsat.2015.11.004. Epub 2015 Nov 25.
5
Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.从监禁中获释、复吸阿片类药物以及丁丙诺啡维持治疗的可能性：对患有阿片类药物使用障碍的前囚犯认知的定性研究
Addict Sci Clin Pract. 2015 Jan 16;10(1):2. doi: 10.1186/s13722-014-0023-0.
6
A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.一项美监狱和看守所中美沙酮维持治疗与强制脱毒随机、开放标签试验：释放后 12 个月的结果。
Drug Alcohol Depend. 2018 Mar 1;184:57-63. doi: 10.1016/j.drugalcdep.2017.11.023. Epub 2018 Jan 31.
7
The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.躯体治疗协作组：美国国立药物滥用研究所关于刑事司法环境中阿片类药物治疗药物疗法的合作研究介绍。
Contemp Clin Trials. 2016 May;48:166-72. doi: 10.1016/j.cct.2016.05.003. Epub 2016 May 11.
8
Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.美沙酮维持治疗可能会提高在社区矫正监督下的阿片类药物依赖者的治疗完成率，并延缓阿片类药物复发。
Addict Behav. 2014 Dec;39(12):1736-40. doi: 10.1016/j.addbeh.2014.07.011. Epub 2014 Jul 10.
9
Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.监禁与阿片类药物戒断：美沙酮治疗患者及戒毒海洛因使用者的经历
J Psychoactive Drugs. 2009 Jun;41(2):145-52. doi: 10.1080/02791072.2009.10399907.
10
Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.马来西亚与接受监狱美沙酮维持治疗意愿相关的因素。
Drug Alcohol Depend. 2016 Jul 1;164:120-127. doi: 10.1016/j.drugalcdep.2016.04.037. Epub 2016 May 9.
引用本文的文献
1
"They won't prosecute, but they will though:" the continuing struggle between criminalization and harm reduction within the criminal justice system in the context of an opioid overdose crisis.“他们不会起诉，但他们会的：”在阿片类药物过量危机背景下，刑事司法系统内将成瘾定为犯罪与减少伤害之间的持续斗争。
Harm Reduct J. 2025 Aug 22;22(1):145. doi: 10.1186/s12954-025-01284-y.
2
Provision of health care services related to substance use disorder in southern U.S. jails.美国南部监狱提供的与物质使用障碍相关的医疗保健服务。
J Subst Use Addict Treat. 2024 Mar;158:209234. doi: 10.1016/j.josat.2023.209234. Epub 2023 Dec 5.
3
Development and use of a checklist for the implementation of medication for opioid use disorder in jails.监狱中阿片类物质使用障碍药物治疗实施清单的制定与应用。
Implement Res Pract. 2022 Jun 7;3:26334895221101214. doi: 10.1177/26334895221101214. eCollection 2022 Jan-Dec.
4
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.马萨诸塞州监禁期间和释放后使用和不使用阿片类药物使用障碍药物相关的估计费用和结果。
JAMA Netw Open. 2023 Apr 3;6(4):e237036. doi: 10.1001/jamanetworkopen.2023.7036.
5
Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.美国受影响严重的县监狱中阿片类药物使用障碍最佳实践的可用性以及相关培训和资源需求：一项全国监狱访谈研究的结果
Health Justice. 2022 Dec 20;10(1):36. doi: 10.1186/s40352-022-00197-3.
6
The impact of the opioid crisis on U.S. state prison systems.阿片类药物危机对美国州立监狱系统的影响。
Health Justice. 2021 Jul 24;9(1):17. doi: 10.1186/s40352-021-00143-9.
7
Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.提高法律体系内退伍军人阿片类药物使用障碍药物治疗实施率的策略：一项定性研究。
J Subst Abuse Treat. 2021 Oct;129:108353. doi: 10.1016/j.jsat.2021.108353. Epub 2021 Mar 4.
8
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.转衔诊所网络：监禁后成瘾治疗、医疗保健和社会支持（TCN-PATHS）：一种增强初级保健的混合 1 型有效性试验，旨在改善从监狱获释后的阿片类药物使用障碍治疗结果。
J Subst Abuse Treat. 2021 Sep;128:108315. doi: 10.1016/j.jsat.2021.108315. Epub 2021 Jan 29.
9
The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons-Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids.瑞士监狱中阿片类激动剂治疗的可及性及其强制中断——辩护律师在处理使用阿片类药物的被拘留者时的态度、认知和经历
Front Psychiatry. 2020 May 14;11:395. doi: 10.3389/fpsyt.2020.00395. eCollection 2020.
10
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.《在刑事司法系统中实施治疗阿片类药物使用障碍药物的障碍和促进因素的范围综述》。
Int J Drug Policy. 2020 Jul;81:102768. doi: 10.1016/j.drugpo.2020.102768. Epub 2020 May 20.
本文引用的文献
1
Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.随机对照试验：与未经咨询即开始美沙酮治疗相比，标准美沙酮治疗：12 个月的结果。
Addiction. 2012 May;107(5):943-52. doi: 10.1111/j.1360-0443.2011.03700.x. Epub 2012 Feb 11.
2
The effectiveness of opioid maintenance treatment in prison settings: a systematic review.监狱环境中阿片类药物维持治疗的效果：系统评价。
Addiction. 2012 Mar;107(3):501-17. doi: 10.1111/j.1360-0443.2011.03676.x.
3
Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.监狱内阿片类药物替代治疗和释放后治疗保留对再监禁风险的影响。
Addiction. 2012 Feb;107(2):372-80. doi: 10.1111/j.1360-0443.2011.03618.x. Epub 2011 Oct 26.
4
Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.美沙酮治疗进入的前因和相关因素：治疗前和治疗中队列的比较。
Drug Alcohol Depend. 2011 May 1;115(1-2):23-9. doi: 10.1016/j.drugalcdep.2010.10.016. Epub 2010 Dec 3.
5
The impact of financial discharge from methadone maintenance therapy on incarceration.美沙酮维持治疗中断对监禁的影响。
J Opioid Manag. 2010 Sep-Oct;6(5):365-70. doi: 10.5055/jom.2010.0034.
6
Premature discharge from methadone treatment: patient perspectives.美沙酮治疗提前出院：患者观点。
J Psychoactive Drugs. 2009 Sep;41(3):285-96. doi: 10.1080/02791072.2009.10400539.
7
Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.监禁与阿片类药物戒断：美沙酮治疗患者及戒毒海洛因使用者的经历
J Psychoactive Drugs. 2009 Jun;41(2):145-52. doi: 10.1080/02791072.2009.10399907.
8
Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.美国监狱系统中美沙酮和丁丙诺啡的处方及转诊实践：一项全国性调查的结果
Drug Alcohol Depend. 2009 Nov 1;105(1-2):83-8. doi: 10.1016/j.drugalcdep.2009.06.015. Epub 2009 Jul 21.
9
A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.一项针对囚犯的美沙酮维持治疗随机临床试验：释放后12个月的结果。
J Subst Abuse Treat. 2009 Oct;37(3):277-85. doi: 10.1016/j.jsat.2009.03.002. Epub 2009 Mar 31.
10
A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes.一项针对男性囚犯美沙酮维持治疗的研究：释放后3个月的结果。
Crim Justice Behav. 2008;35(1):34-47. doi: 10.1177/0093854807309111.
Zotero 插件